Citigroup’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Citigroup's RGEN Position: Q1 2026 in Review
Citigroup reduced its Repligen (RGEN) stake by 57% in Q1 2026, selling an estimated $6.62M and leaving 36,356 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2086.
Citigroup first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.9M in Q3 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Citigroup held 36,356 shares of Repligen worth $4.28M as of Q1 2026.
- Citigroup sold 47,396 Repligen shares in Q1 2026, an estimated $6.62M.
- Repligen made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2086 holding.
- Citigroup first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Repligen position peaked at $13.9M in Q3 2024.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.